Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25017020 | 1.00 | PRKDC (0.33) | PRKDC | |
| SCHEMBL25017316 | 0.95 | TERT (0.30) | PRKDC | |
| SCHEMBL25017416 | 0.94 | TERT (0.30) | — | |
| SCHEMBL25016967 | 0.94 | TERT (0.30) | — | |
| SCHEMBL25016584 | 0.92 | MAPT (0.31) | — | |
| SCHEMBL25017107 | 0.92 | TERT (0.30) | PRKDC | |
| SCHEMBL25972815 | 0.91 | PRKDC (0.33) | PRKDC | |
| SCHEMBL25017158 | 0.90 | TSHR (0.30) | — | |
| SCHEMBL25017320 | 0.90 | TNKS (0.31) | — | |
| SCHEMBL22329214 | 0.90 | PRKDC (0.37) | PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578076-B2 | Heterocyclic compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578076-B2 | Heterocyclic compound and organic light emitting device using the same | CYBA, SUN2, TMEM109 | PRKDC 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.